| Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial AM Dondorp, CI Fanello, ICE Hendriksen, E Gomes, A Seni, ... The Lancet 376 (9753), 1647-1657, 2010 | 1115 | 2010 |
| Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age P Bejon, J Lusingu, A Olotu, A Leach, M Lievens, J Vekemans, S Mshamu, ... New England Journal of Medicine 359 (24), 2521-2532, 2008 | 529 | 2008 |
| Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine DE Neafsey, M Juraska, T Bedford, D Benkeser, C Valim, A Griggs, ... New England Journal of Medicine 373 (21), 2025-2037, 2015 | 418 | 2015 |
| Identification of hot spots of malaria transmission for targeted malaria control T Bousema, C Drakeley, S Gesase, R Hashim, S Magesa, F Mosha, ... The Journal of infectious diseases 201 (11), 1764-1774, 2010 | 361 | 2010 |
| Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial MT White, R Verity, JT Griffin, KP Asante, S Owusu-Agyei, B Greenwood, ... The Lancet infectious diseases 15 (12), 1450-1458, 2015 | 339 | 2015 |
| Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial L Von Seidlein, R Olaosebikan, ICE Hendriksen, SJ Lee, OT Adedoyin, ... Clinical infectious diseases 54 (8), 1080-1090, 2012 | 229 | 2012 |
| Efficacy of RTS, S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a … A Olotu, J Lusingu, A Leach, M Lievens, J Vekemans, S Msham, T Lang, ... The Lancet infectious diseases 11 (2), 102-109, 2011 | 219 | 2011 |
| Rapid assessment of malaria transmission using age-specific sero-conversion rates L Stewart, R Gosling, J Griffin, S Gesase, J Campo, R Hashim, P Masika, ... PloS one 4 (6), e6083, 2009 | 194 | 2009 |
| High Resistance of Plasmodium falciparum to Sulphadoxine/Pyrimethamine in Northern Tanzania and the Emergence of dhps Resistance Mutation at Codon 581 S Gesase, RD Gosling, R Hashim, R Ord, I Naidoo, R Madebe, JF Mosha, ... PLoS One 4 (2), e4569, 2009 | 189 | 2009 |
| Diagnosing Severe Falciparum Malaria in Parasitaemic African Children: A Prospective Evaluation of Plasma PfHRP2 Measurement ICE Hendriksen, J Mwanga-Amumpaire, L Von Seidlein, G Mtove, ... Public Library of Science 9 (8), e1001297, 2012 | 149 | 2012 |
| Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial RD Gosling, S Gesase, JF Mosha, I Carneiro, R Hashim, M Lemnge, ... The Lancet 374 (9700), 1521-1532, 2009 | 136 | 2009 |
| Defining Falciparum-Malaria-Attributable Severe Febrile Illness in Moderate-to-High Transmission Settings on the Basis of Plasma PfHRP2 Concentration ICE Hendriksen, LJ White, J Veenemans, G Mtove, C Woodrow, B Amos, ... The Journal of infectious diseases 207 (2), 351-361, 2013 | 96 | 2013 |
| Is housing quality associated with malaria incidence among young children and mosquito vector numbers? Evidence from Korogwe, Tanzania JX Liu, T Bousema, B Zelman, S Gesase, R Hashim, C Maxwell, ... PloS one 9 (2), e87358, 2014 | 75 | 2014 |
| Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa Y Lubell, A Riewpaiboon, AM Dondorp, L Seidlein, OA Mokuolu, ... Bulletin of the World Health Organization 89, 504-512, 2011 | 71 | 2011 |
| Evaluation of a PfHRP2 and a pLDH-based Rapid Diagnostic Test for the Diagnosis of Severe Malaria in 2 Populations of African Children ICE Hendriksen, G Mtove, AJ Pedro, E Gomes, K Silamut, SJ Lee, ... Clinical infectious diseases 52 (9), 1100-1107, 2011 | 69 | 2011 |
| Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 … SB Sirima, B Ogutu, JPA Lusingu, A Mtoro, Z Mrango, A Ouedraogo, ... The Lancet Infectious Diseases 16 (10), 1123-1133, 2016 | 64 | 2016 |
| Long-term incidence of severe malaria following RTS, S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised … H Tinto, W Otieno, S Gesase, H Sorgho, L Otieno, E Liheluka, I Valéa, ... The Lancet Infectious Diseases 19 (8), 821-832, 2019 | 61 | 2019 |
| Safety profile of the RTS, S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa YG Mendoza, E Garric, A Leach, M Lievens, O Ofori-Anyinam, JY Pirçon, ... Human vaccines & immunotherapeutics, 2019 | 59 | 2019 |
| Levels of Plasma Immunoglobulin G with Specificity against the Cysteine-Rich Interdomain Regions of a Semiconserved Plasmodium falciparum Erythrocyte … JPA Lusingu, ATR Jensen, LS Vestergaard, DT Minja, MB Dalgaard, ... Infection and immunity 74 (5), 2867-2875, 2006 | 59 | 2006 |
| Population pharmacokinetics of intramuscular artesunate in African children with severe malaria: implications for a practical dosing regimen ICE Hendriksen, G Mtove, A Kent, S Gesase, H Reyburn, MM Lemnge, ... CliNiCAl PHARMACOlOgy & THERAPEuTiCS 93 (5), 443-450, 2013 | 57 | 2013 |
